The global anesthesia drugs market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The rising number of surgeries, new anesthetic drug approvals, and the growing use of local anesthetics in post-operative pain are driving the growth of the global anesthesia drugs market. The increasing number of surgeries is a major factor driving market growth during the study period. For instance, in 2020, According to the American Society of Plastic Surgeons Plastic Surgery Statistics Report, the total number of cosmetic procedures performed in the United States in 2020 was 2,314,720, including 211,067 liposuction procedures. As anesthesia is commonly used in such procedures, an increase in the number of such surgeries will drive up demand for anesthesia drugs.
A full report of Wooden Decking Market is available at:https://orionmarketreports.com/global-anesthesia-drugs-market/92787/
Furthermore, the development and approval of novel local anesthesia drugs demonstrate a new revenue-generating resource for market participants. For instance, in February 2021, PainPass launched the first Cannabidiol (CBD)/lidocaine product line that specifically targets those suffering from chronic pain and external muscle numbness.
Additionally, in June 2020, Medova and the New York School of Regional Anesthesia (NYSORA) will collaborateto launch SAFIRA (SAFer Injection for Regional Anesthesia) in the United States. In addition, in January 2020, the Food and Drug Administration approved a new drug application for Lannett Company’s cocaine hydrochloride (HCI; NUMBRINO) nasal solution 4 percent (40 mg/mL) for anesthetic use in the United States.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Type
- By Route of Administration
- End User
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape- Abbott Laboratories, Astrazeneca PLC, Baxter International Inc., Hospira, Inc., F. Hoffmann-La Roche Ltd., Hikma Pharmaceuticals PLC, AbbVie Inc.,among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Anesthesia Drugs Market Report by Segment
By Type
- Propofol
- Sevoflurane
- Dexmedetomidine
- Desflurane
- Remifentanil
- Midazolam
- Others
By Route of Administration
- Inhalation
- Injection
- Topical
- Others
By End User
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
